ICO-IO Combinations Summit 2019

Evvnt Promotion / evvnt
Archivio
-
19.03.2019 - 21.03.2019  The Colonnade Boston Hotel, 120 Huntington Avenue, 02116 Boston, USA
Time: 9:00 am to 5:00 pm
 
Temi della conferenza
Advancing ICI-containing IO-combination therapies is central to getting the full therapeutic benefit out of ICIs. Selecting the right combination partners and strategies are essential to the making the correct decision.

This industry-led meeting will focus on how the response rate to checkpoint combinations can be enhanced to impact every stage of the cancer immunity cycle, as well as shed light on the specific challenges that come with combining IO therapies with ICIs.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Sarah McWhirter Aduro Biotech, Jeremy Graff Biothera, Jochem Gokelmeijer Bristol-Myers Squibb, Mark Paris Director Mitra Biotech, Mithun Khattar Takeda, Osama Rahma Dana-Faber Cancer Center, Patrick Holder Genentech and many more.
 

Informazioni ed Iscrizioni:

http://go.evvnt.com/319454-2?pid=4832
Customer Services
 
Categorie
Servizi sanitari
Lingua
Inglese
Quote del Congresso
USD 2.899,00
(Conference Only (early bird): USD 2599.0, Conference Only (standard): USD 2899.0)
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Alumni Club Medizinische Universität WienAnästhesie in Entwicklungsländern e. V.Hilfswerk AustriaOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Charité International AcademyÖsterreichische Gesellschaft für Public HealthCenter of ExcellenceEuropean Health Forum Gastein